EBioMedicine (May 2018)

A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer

  • Shao-Xu Wu,
  • Jian Huang,
  • Zhuo-Wei Liu,
  • Hai-Ge Chen,
  • Pi Guo,
  • Qing-Qing Cai,
  • Jun-Jiong Zheng,
  • Hai-De Qin,
  • Zao-Song Zheng,
  • Xin Chen,
  • Rui-Yun Zhang,
  • Si-Liang Chen,
  • Tian-Xin Lin

Journal volume & issue
Vol. 31
pp. 54 – 65

Abstract

Read online

Preoperative lymph node (LN) status is important for the treatment of bladder cancer (BCa). Here, we report a genomic-clinicopathologic nomogram for preoperatively predicting LN metastasis in BCa. In the discovery stage, 325 BCa patients from TCGA were involved and LN-status-related mRNAs were selected. In the training stage, multivariate logistic regression analysis was used to developed a genomic-clinicopathologic nomogram for preoperative LN metastasis prediction in the training set (SYSMH set, n = 178). In the validation stage, we validated the nomogram using two independent sample sets (SYSUCC set, n = 142; RJH set, n = 104) with respect to its discrimination, calibration and clinical usefulness. As results, we identified five LN-status-related mRNAs, including ADRA1D, COL10A1, DKK2, HIST2H3D and MMP11. Then, a genomic classifier was developed to classify patients into high- and low-risk groups in the training set. Furthermore, a nomogram incorporating the five-mRNA-based classifier, image-based LN status, transurethral resection (TUR) T stage, and TUR lymphovascular invasion (LVI) was constructed in the training set, which performed well in the training and validation sets. Decision curve analysis demonstrated the clinical value of our nomogram. Thus, our genomic-clinicopathologic nomogram shows favorable discriminatory ability and may aid in clinical decision-making, especially for cN-patients. Keywords: Genomics, Lymphatic metastasis, Nomogram, Urinary bladder neoplasms